Willis Johnson & Associates’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-1,607
Closed -$229K 172
2024
Q2
$229K Sell
1,607
-74
-4% -$10.6K 0.02% 140
2024
Q1
$216K Buy
+1,681
New +$216K 0.02% 140